Leaflet EKTEBIN 250mg film-coated tablets


Indicated for: tuberculosis

Route of administration: oral

Substance: protionamide (anti-tuberculosis agent)

ATC: J04AD01 (Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Thiocarbamide derivatives)

Prothionamide is a medication used in the treatment of drug-resistant tuberculosis and other infections caused by mycobacteria. It works by inhibiting the synthesis of mycolic acids, which are essential for the bacterial cell wall.

The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to adhere to the treatment regimen to prevent the development of bacterial resistance.

Side effects may include nausea, vomiting, abdominal pain, or liver disturbances. In rare cases, severe allergic reactions or psychiatric disorders may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver diseases, to ensure the safe use of prothionamide.

General data about EKTEBIN 250mg

  • Substance: protionamide
  • Date of last drug list: 01-07-2013
  • Commercial code: W41489001
  • Concentration: 250mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 50
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for protionamide